vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Maxeon Solar Technologies, Ltd. (MAXN). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $509.0M, roughly 2.4× Maxeon Solar Technologies, Ltd.). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs -120.7%, a 121.6% gap on every dollar of revenue. On growth, Maxeon Solar Technologies, Ltd. posted the faster year-over-year revenue change (-54.7% vs -74.7%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Maxeon Solar Technologies, Ltd. is a Singapore-based company that designs and manufactures photovoltaic panels. The company was previously a division of the American company SunPower. Maxeon was spun off from SunPower in August 2020. Maxeon was the primary provider of solar panels for SunPower through March 2024. Beyond the United States, Maxeon has sales operations in more than 100 countries and has the rights to use the SunPower brand in countries outside the United States.

ALHC vs MAXN — Head-to-Head

Bigger by revenue
ALHC
ALHC
2.4× larger
ALHC
$1.2B
$509.0M
MAXN
Growing faster (revenue YoY)
MAXN
MAXN
+20.1% gap
MAXN
-54.7%
-74.7%
ALHC
Higher net margin
ALHC
ALHC
121.6% more per $
ALHC
0.9%
-120.7%
MAXN

Income Statement — Q1 FY2026 vs Q4 FY2024

Metric
ALHC
ALHC
MAXN
MAXN
Revenue
$1.2B
$509.0M
Net Profit
$11.4M
$-614.3M
Gross Margin
Operating Margin
-113.3%
Net Margin
0.9%
-120.7%
Revenue YoY
-74.7%
-54.7%
Net Profit YoY
-122.7%
EPS (diluted)
$-96.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
MAXN
MAXN
Q1 26
$1.2B
Q4 25
$1.0B
Q3 25
$993.7M
Q2 25
$1.0B
Q1 25
$926.9M
Q4 24
$701.2M
$509.0M
Q3 24
$692.4M
Q2 24
$681.3M
Net Profit
ALHC
ALHC
MAXN
MAXN
Q1 26
$11.4M
Q4 25
$-11.0M
Q3 25
$3.7M
Q2 25
$15.7M
Q1 25
$-9.1M
Q4 24
$-31.1M
$-614.3M
Q3 24
$-26.4M
Q2 24
$-24.0M
Operating Margin
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
-1.0%
Q3 25
0.8%
Q2 25
2.2%
Q1 25
-0.6%
Q4 24
-3.2%
-113.3%
Q3 24
-2.8%
Q2 24
-2.7%
Net Margin
ALHC
ALHC
MAXN
MAXN
Q1 26
0.9%
Q4 25
-1.1%
Q3 25
0.4%
Q2 25
1.5%
Q1 25
-1.0%
Q4 24
-4.4%
-120.7%
Q3 24
-3.8%
Q2 24
-3.5%
EPS (diluted)
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
$-0.04
Q3 25
$0.02
Q2 25
$0.07
Q1 25
$-0.05
Q4 24
$-0.15
$-96.00
Q3 24
$-0.14
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
MAXN
MAXN
Cash + ST InvestmentsLiquidity on hand
$705.6M
$28.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$-293.8M
Total Assets
$1.3B
$376.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
MAXN
MAXN
Q1 26
$705.6M
Q4 25
$604.2M
Q3 25
$644.1M
Q2 25
$503.8M
Q1 25
$479.5M
Q4 24
$470.6M
$28.9M
Q3 24
$381.0M
Q2 24
$363.7M
Total Debt
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
MAXN
MAXN
Q1 26
$206.9M
Q4 25
$179.3M
Q3 25
$161.9M
Q2 25
$141.0M
Q1 25
$108.1M
Q4 24
$99.9M
$-293.8M
Q3 24
$114.5M
Q2 24
$123.7M
Total Assets
ALHC
ALHC
MAXN
MAXN
Q1 26
$1.3B
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.0B
Q1 25
$895.6M
Q4 24
$782.1M
$376.3M
Q3 24
$692.3M
Q2 24
$716.3M
Debt / Equity
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
MAXN
MAXN
Operating Cash FlowLast quarter
$128.7M
$-270.2M
Free Cash FlowOCF − Capex
$-322.3M
FCF MarginFCF / Revenue
-63.3%
Capex IntensityCapex / Revenue
10.2%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
MAXN
MAXN
Q1 26
$128.7M
Q4 25
$-50.4M
Q3 25
$144.6M
Q2 25
$29.1M
Q1 25
$16.6M
Q4 24
$-8.7M
$-270.2M
Q3 24
$26.2M
Q2 24
$23.5M
Free Cash Flow
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
$-322.3M
Q3 24
$16.9M
Q2 24
$11.8M
FCF Margin
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
-63.3%
Q3 24
2.4%
Q2 24
1.7%
Capex Intensity
ALHC
ALHC
MAXN
MAXN
Q1 26
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
10.2%
Q3 24
1.3%
Q2 24
1.7%
Cash Conversion
ALHC
ALHC
MAXN
MAXN
Q1 26
11.27×
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons